Product Information
RISPERIDONE 2 MG TABLET is a generic product labeled by Ajanta Pharma USA Inc., priced at $0.0544 per EA under NDC 27241000406. Its NADAC has been published 638 times since Jul 16, 2014.
FDA first approved this application on Aug 24, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 mg/1
Manufacturer
Ajanta Pharma USA Inc.NDC
27241000406
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
RISPERIDONEApproval Type
Generic (ANDA)
FDA Application
ANDA201003FDA Approved
8/24/2011
TE Code
AB
On Market Since
3/28/2014
Pharmacological Classes
Price Statistics
The NADAC for RISPERIDONE 2 MG TABLET has been published 638 times since Jul 16, 2014, and over the history we have for it it has declined 55.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0544 per EA |
|---|---|
| All-time high | $0.1222 (Jun 10, 2015) |
| All-time low | $0.0434 (Dec 18, 2024) |
| 52-week high | $0.0555 |
| 52-week low | $0.0491 |
| Median price | $0.0647 |
| Average price | $0.0713 |
| Largest weekly change | -27.8% (Dec 21, 2022) |
| Weeks tracked | 638 |
| Tracking since | Jul 16, 2014 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ajanta Pharma USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
RISPERIDONE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of RISPERIDONE 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RISPERIDONE 2 MG TABLET, manufactured by Ajanta Pharma USA Inc., is $0.0544 per EA (NDC 27241000406), effective Sep 30, 2026.
How has the price of RISPERIDONE 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for RISPERIDONE 2 MG TABLET has declined 55.2%. It has been tracked across 638 weekly CMS publications since Jul 16, 2014.
What are the highest and lowest recorded NADAC prices for RISPERIDONE 2 MG TABLET?
Since Jul 16, 2014, the NADAC for RISPERIDONE 2 MG TABLET has ranged from a low of $0.0434 (Dec 18, 2024) to a high of $0.1222 (Jun 10, 2015), with a median of $0.0647 per EA.
Are there cheaper alternatives to RISPERIDONE 2 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as RISPERIDONE 2 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures RISPERIDONE 2 MG TABLET?
RISPERIDONE 2 MG TABLET (NDC 27241000406) is labeled by Ajanta Pharma USA Inc., and CMS classifies it as a generic product.